Book a consultation

Launching ZELSUVMI™: Breaking Through in Dermatology with Nitric Oxide Innovation

Project Objectives

  • Raise awareness of metal-coordination chemistry in precision therapeutics.
  • Establish authoritieship among translational pharma partners and investors.
  • Support business development for licensing of pipeline assets.

Challenges

  • Metallodrugs are niche—limited awareness outside specialist circles.
  • Complex scientific mechanisms hard to communicate simply.
  • Early-stage pipeline requiring credible external validation.

Our Approach

  1. Simplified brand framework – Crafted clear messaging positioning MetalDrug as programmable “Metal Logic” therapeutics.
  2. Whitepaper and visuals – Produced infographic-rich assets explaining coordination chemistry & pipeline-stage therapies.
  3. Influencer engagement – Partnered with key academic researchers to co-author content.
  4. ABM campaigns – Targeted pharmacoengineering, CMC, and BD teams at biotech/pharma firms.

Results

  • 4× growth in BD inbound inquiries.
  • Featured in 2 pharma innovation publications.
  • 3 partnerships signed to advance preclinical candidates.

Conclusion

By demystifying metallodrugs and leveraging scientific authority, Accelabrand elevated MetalDrug’s market position for business development acceleration.